Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15111351 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting FMISO-PET in Brain Tumors and SCS Effect
Condition: Malignant Glioma
Interventions: Drug: 18F-FMISO;   Procedure: PET without SCS;   Device: SCS;   Procedure: PET without/with SCS;   Radiation: Radiotherapy;   Drug: Temozolomide

Indicates status has not been verified in more than two years